Mira Innovation Technologies Secures Nearly RMB 100 Million in Pre-A Financing Round

VCBeat has learned at the earliest opportunity that,AIMIRA Recently Completes Nearly RMB 100 Million Pre-A Financing Round Led by BioTrack Capital, with Participation from JINDING CAPITAL, Fosun Health Capital, and CDF Capital; G&G Capital Serves as Exclusive Financial Advisor

The AIMIRA team brings together top R&D talent from China, the United Kingdom, the United States, and Australia. Co-founded by senior clinical medical experts, MIT hardware specialists, and algorithm experts, the company has established leading AI algorithms and hardware platforms. Leveraging abundant industrial resources and addressing critical clinical pain points, AIMIRA is dedicated to developing groundbreaking innovative medical robots under its AIMIRA brand series, targeting fields such as ophthalmology, anti-aging, medical aesthetics, and dermatology. Currently, the company has completed the development of two products, which are poised to enter clinical trials and commercial promotion stages respectively, with plans to launch three new products by the end of this year.